9:00 |
SESSION VIII: NEW THERAPEUTIC APPROACHES
Chairs: Alain Lafeuillade (Toulon, France), Robert Gallo (Baltimore, USA)
|
| 9:00 |
HIV Reservoirs in the Era of Effective Antiretroviral Therapy: Perspectives for Therapeutic Intervention and Eradication
Tae-Wook Chun (National Institute of Allergy and Infectious Diseases, Bethesda, USA) |
| 9:20 |
Killing of Latently HIV-infected Cells
Yuntao Wu (George Mason University, USA) |
| 9:40 |
Rational Design of First-in-class Inhibitors of LEDGF/p75-integrase Interaction and HIV Replication Zeger Debyser (Molecular Medicine, KULeuven, Leuven, Belgium) |
| 10:00 |
“Shock and Kill” Research to Combat HIV-1 Latency
Andrea Savarino (Istituto Superiore di Sanità, Rome, Italy) |
| 10:15 |
Correlation Between the Isoform Specificity of HDAC Inhibitors and their Ability to Reactivate Latent HIV-1 Infection
Nicolas Sluis-Cremer (University of Pittsburgh, Pittsburgh, USA) |
| 10:30 |
Novel Small Molecule Transcriptional Inhibitors of HIV-1 which Suppress Virus Production from Infected Cells
Robert Buckheit (ImQuest BioSciences, Inc., Frederick, USA) |
| 10:45 |
Successful Targeting and Disruption of Integrated Lentiviral Sequences Using an Engineered Homing Endonuclease
Keith Jerome (Fred Hutchinson Cancer Research Center, Seattle, USA) |
| 11:00 |
Increased HIV-specific Immunity in HIV-infected Individuals Vaccinated with a DNA Prime, rAd5
Boost Regimen
Joe Casazza (VRC/NIAID/NIH, Bethesda, USA) |
12:00 |
Workshop Conclusions
Robert Gallo (Baltimore, USA), Alain Lafeuillade (Toulon, France), Mario Stevenson (Worcester, USA) |
|
